University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Qingsheng Li Publications

Papers in the Biological Sciences

2008

Simian Immunodeficiency Virus–Induced
Intestinal Cell Apoptosis Is the Underlying
Mechanism of the Regenerative Enteropathy of
Early Infection
Qingsheng Li
University of Minnesota, Minneapolis, qli4@unl.edu

Jacob D. Estes
University of Minnesota, Minneapolis, estesj@mail.nih.gov

Lijie Duan
University of Minnesota, Minneapolis

Jose Jessurun
University of Minnesota, Minneapolis

Stefan Pambuccian
University of Minnesota, Minneapolis
See next page for additional authors

Follow this and additional works at: https://digitalcommons.unl.edu/biosciqingshengli
Li, Qingsheng; Estes, Jacob D.; Duan, Lijie; Jessurun, Jose; Pambuccian, Stefan; Forster, Colleen; Wietgrefe, Stephen; Zupancic, Mary;
Schacker, Timothy; Reilly, Cavan; Carlis, John V.; and Haase, Ashley T., "Simian Immunodeficiency Virus–Induced Intestinal Cell
Apoptosis Is the Underlying Mechanism of the Regenerative Enteropathy of Early Infection" (2008). Qingsheng Li Publications. 13.
https://digitalcommons.unl.edu/biosciqingshengli/13

This Article is brought to you for free and open access by the Papers in the Biological Sciences at DigitalCommons@University of Nebraska - Lincoln.
It has been accepted for inclusion in Qingsheng Li Publications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln.

Authors

Qingsheng Li, Jacob D. Estes, Lijie Duan, Jose Jessurun, Stefan Pambuccian, Colleen Forster, Stephen
Wietgrefe, Mary Zupancic, Timothy Schacker, Cavan Reilly, John V. Carlis, and Ashley T. Haase

This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/biosciqingshengli/13

Published in The Journal of Infectious Diseases 197 (2008), pp. 420–429. doi: 10.1086/525046
Copyright © 2008 Infectious Diseases Society of America. Used by permission.
Submitted April 9, 2007; accepted May 21, 2007; published online January 16, 2008.
digitalcommons.unl.edu

Simian Immunodeficiency Virus–Induced Intestinal Cell
Apoptosis Is the Underlying Mechanism of the
Regenerative Enteropathy of Early Infection
Qingsheng Li,1 Jacob D. Estes,1 Lijie Duan,1 Jose Jessurun,2 Stefan Pambuccian,2
Colleen Forster,3 Stephen Wietgrefe,1 Mary Zupancic,1 Timothy Schacker,4
Cavan Reilly,5 John V. Carlis,6 and Ashley T. Haase1
University of Minnesota, Minneapolis:
1. Department of Microbiology
2. Department of Laboratory Medicine and Pathology
3. Neuropathology Laboratory, Department of Laboratory Medicine and Pathology
4. Division of Infectious Diseases, Department of Medicine, Medical School
5. Division of Biostatistics, School of Public Health
6. Department of Computer Science and Engineering, Institute of Technology
Corresponding author – Ashley T. Haase, Dept. of Microbiology, University of Minnesota,
MMC 196, 420 Delaware St. SE, Minneapolis, MN 55455; email haase001@umn.edu

Abstract
The enteropathic manifestations of the human immunodeficiency virus (HIV) and the simian immunodeficiency virus (SIV) in late infection are usually due to infection by other microbes, but in early infection the viruses themselves cause an enteropathy by heretofore undetermined mechanisms. Here we report that SIV induces massive apoptosis of intestinal epithelial cells lining the small and large bowel, thus identifying apoptosis
as the driving force behind the regenerative pathology of early infection. We found that apoptosis of gut epithelium paralleled the previously documented apoptosis and massive depletion of CD4 T cells in gut lamina
propria, triggered by established mechanisms of gut epithelial cell apoptosis and, at peak, possibly by virus interactions with GPR15/Bob, an intestinal epithelial cell–associated alternative coreceptor for SIV and HIV-1.
Apoptosis in early SIV infection is thus the common theme of the pathological processes that quickly afflict the
innate as well as adaptive arms of the gut immune system.

Diarrhea, malabsorption, and weight loss, enteropathic
manifestations of HIV type 1 (HIV-1) [1–4], and simian immunodeficiency virus (SIV) infections [5–7] are usually the
result of concurrent infection by other viruses, bacteria,
and protozoa in the later stages of infection. However, both
HIV-1 [8] and SIV can themselves, in the absence of other
enteric pathogens, cause malabsorption and histopatholgical changes in the gut that are detectable as early as the end
of the second week of SIV infection [6, 7]. The underlying
mechanism of these earlystage-HIV and -SIV enteropathies
are unknown, but the increased expression of cell-cycle
genes [9, 10] and pathological changes of regenerative villous atrophy [5, 7, 11] point to infection-induced increases
in turnover of gut epithelium.
We sought the antecedent causes of the enteropathy and increased turnover of gut epithelium in tissues
collected in the course of published studies [12] of the

SIVnonhuman- primate (rhesus macaque) model of HIV-1
vaginal transmission and early infection. We reasoned that
these tissues might provide an opportunity to discover virus-induced mechanisms of increased turnover and enteropathy in the time frame when they might be the most apparent, between 7 days postinoculation (dpi) and 10–14 dpi. The
former is the time infection had disseminated from the vaginal site of inoculation to gutassociated and other lymphatic
tissues, whereas the latter is the peak period of viral replication in the gut and throughout the lymphatic tissues and the
time at which evidence of increased turnover of gut epithelium had been previously documented [7, 9–11]. We now report that, within this short period, there is massive apoptosis
and an associated increase in proliferation of gut epithelium,
which identify apoptosis of gut epithelium as the underlying mechanism of the regenerative villous atrophy that characterizes the gut pathology of early infection.
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shown to be specific, on the basis of the lack of staining
with the isotype control. For the antibodies used, sources,
dilutions, and other details, see table 2.

Table 1. Information on the animals and status of tissues.
			
Cervical/
Day(s)
vaginal
Gut
postinoculationa infection
infection

of

Gut lamina propria
CD4 T cells
Depletion

Apoptosis

–
–
+
3+
3+
3+

–
–
3+
±
±
±

Key: –, not detected; +, detected on scale of 1–3; ±, detected at low
frequency. Data are from Miller et al. [12] and Li et al. [13].
a. Infection of tissues was determined by detection of simian immunodeficiency virus RNA+ cells, by in situ hybridization.

Materials and Methods
Gut tissues from SIV-infected animals. Colon and smallbowel tissues were obtained at necropsy 1–28 days after
adult female rhesus macaques (Macacca mulatta) had been
inoculated intravaginally twice the same day with 1 × 105
of 50% tissueculture infectious dose of either SIVmac251 or
SIVmac239, as described by Miller et al. [12] and summarized in table 1. Tissues were fixed in paraformaldehyde or
Streck’s Tissue Fixative before being embedded in paraffin.
Immunohistochemistry. Tissue sections (5–8 µm) fixed
in either paraformaldehyde or Streck’s Tissue Fixative
were rehydrated in deionized distilled water and blocked
for endogenous peroxidase activity by being immersed
in 3% H2O2 in methanol for 30 min. For antigen retrieval,
slides were incubated in either citrate buffer (10 mmol/L,
pH 6.0), EDTA (1 mmol/L, pH 8.0), EDTA Decloaker (Biocare Medical), or Reveal buffer (Biocare Medical) for 20
min at 95°C–98°C, and, after cooling for 20 min, the slides
were immersed in 3% normal serum in TNB (TNB blocking buffer, 0.1 mol/L Tris-HCl, pH 7.5; 0.15 mol/L NaCl;
0.5% blocking reagent [Dupont]) for 30 min and in BACKGROUND SNIPER (Biocare Medical) for 10 min–1 h. The
sections were then incubated overnight at 4°C in a humidified chamber with primary antibodies (table 2) diluted in
either 10% BACKGROUND SNIPER or, as a negative control, isotype control immunoglobulin. After being rinsed,
the sections were developed by staining, according to the
manufacturer’s instructions, in one of the following systems: biotin-free mouse DakoCytomation EnVision+ System-HRP (Dako), MACH-3 mouse–horseradish peroxidase
(HRP) polymer (Biocare Medical), MACH-3 rabbit-probe
HRP polymer (Biocare Medical), MACH-3 mouse-probe
alkaline phosphatase polymer (Biocare Medical) and HRP
substrate diaminobenzidine (DAB), or alkaline-phosphatase substrate Vulcan Fast Red (Biocare Medical). The sections were then counterstained with hematoxylin (Biocare
Medical), for the Fast Red substrate, and Harris hematoxylin (Surgipath Medical), for the DAB substrate. All immunohistochemical (and immunofluorescent) staining was

Immunofluorescence and confocal microscopy. As has
been described by Li et al. [13], sections were stained with
primary antibodies overnight at 4°C, were washed in PBSTween20 (0.05% v/v), and incubated, for 1 h at room temperature, with donkey secondary antibodies with minimal cross-reactivity that were conjugated with Alexa 488
(green) or 555 (red). Cell nuclei were counterstained blue
withTOTO-3.ABio-RadMRC1000 confocal microscope was
used to collect, at wavelengths specific for each fluorophore, confocal images at 600× or 1200× magnification, by
acquiring, at every time point analyzed, the brightest point
projection from at least 12–18 randomly selected regions
of the small and large bowel. For every image collected,
each fluorescence channel was sequentially acquired, binary images were imported into Adobe Photoshop CS Photoshop, were converted into red/green/blue color images,
and were merged to generate either dual- or triple-labeled
images. To allow better visualization of the GPR15/Bob
receptor translocation and alterations, some images not
showing nuclear staining are also shown.
In situ hybridization. SIV RNA was detected, by in situ
hybridization, in paraformaldehyde-fixed and paraffin-embedded tissues, as described by Li et al. [13]. In brief, 6–8
µm sections were cut and adhered to slides treated with
3-aminopropyltrioxysilane. After deparaffinization in xylene, rehydration in PBS, and permeabilization by treating
the sections with HCl, digitonin, and proteinase K, the sections were acetylated and hybridized to 35S-labeled SIVspecific riboprobes. After being washed and digested with ribonucleases, the sections were coated with nuclear-track
emulsion, were exposed and developed, and were counterstained with Wright.
Quantification of gut epithelial cell apoptosis and proliferation. We quantified apoptosis and proliferation by using an approach similar to that described by Holubec et al.
[14]. Images of colon tissue immunohistochemically stained
to detect cleaved cytokeratin 18 or Ki67 and counterstained
with hematoxylin were randomly captured by use of Scion
visiCapture software (version 1.3) and an Olympus BX60
microscope (20x/numeric aperture 0.70) coupled with a
Scion Color IEEE-1394 Camera (Scion). Cleaved CK18+ gut
epithelial cells and total gut epithelial nuclei in 30 fields
at 200× magnification were enumerated manually and independently by 2 investigators using Adobe Photoshop
CS2. Apoptosis was expressed as the mean percentage of
cleaved CK18+ cells and nuclei counted. Colonic proliferating Ki67+ cells were similarly quantified in crypts, in which
the bases, middle portions, and tops were in the same focal plane.
Table 2. Details on antibodies used. The table is available
following page 429.
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Figure 1. Apoptosis of gut epithelial cells and lamina propria cells in small and large bowel, in early simian immunodeficiency virus infection. Activated caspase-3 as a marker of apoptosis was detected immunohistochemically by use of Vulcan Fast Red substrate. In panel A, the larger arrow indicates one of several red-stained apoptotic gut epithelial cells lining a cross-section of jejunal
villi at the onset of viral replication in gut, and the smaller arrow indicates one of many red-stained activated caspase-3+ apoptotic
cells in the lamina propria, which elsewhere have been shown to be effector memory CD4+ T cells [13]. The inset shows the negligible staining in a section of jejunum from an uninfected animal. Original magnification, ×200. In panel B, the large arrow indicates
one of several apoptotic gut epithelial cells lining the colon, and the small arrow indicates apoptotic lamina propria cells at the onset of viral replication in gut. Original magnification, ×400.
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Figure 2. Time course of increased gut epithelial cell apoptosis in the large bowel. A–C, Apoptotic epithelial cells stained red with
antibodies to cleaved cytokeratin 18, a specific marker for epithelial cell apoptosis, and Vulcan Fast Red substrate. Note the increasing number of red-staining apoptotic cells lining the bowel, in an uninfected animal (A) and in an animal at the onset (B) and
peak (C) of gut infection. Original magnifications, ×200. D, Percentage of apoptotic gut epithelial cells in large bowel, determined
as described in Materials and Methods, in 2 animals per time point, for the indicated days after intravaginal inoculation. Days 0
and 2 (0–2) are, respectively, before inoculation and before spread of infection to gut; days 7 and 8 are the initial phase of gut infection, days 13 and 14 are the broad peak of replication, and days 20, 21, and 28 are the decline phase, in return to set-point levels. Error bars indicate SEs.

Statistical tests. To examine the overall effect, at various
weeks postinfection, on the levels of cytokeratin 18 and
Ki67, we fit an analysis-of-variance model and used the F
statistic to test for an effect of time (with weeks postinfection being treated as a factor). This method allows us to investigate the effect of time without having to assume some
form for the relationship (such as linear) between levels
and time. To then test for differences between baseline levels and those at specific days, we used the 2-sample t test
(with equal variances). To control the overall significance
level for each response of interest, a Bonferonni adjustment
was used for these t tests.
Results
Gut epithelial cell apoptosis in early SIV infection.
Elsewhere, we already had shown that, at 7–14 dpi, there
was massive depletion of memory CD4+ T cells and that
this coincided with commensurate increases in apoptosis

of lamina propriaCD4+ T cells [13], as is illustrated, in figure 1, by the large number of activated caspase 3+ cells in
small-bowel lamina propria at 8 dpi, a result supporting
our previously reported conclusion [13] that apoptosis of
CD4+ T cells contributed significantly to CD4+ T cell depletion in the gut. However, as is evident in figure 1, we also
observed focal increases in activated caspase-3+ apoptotic
gut epithelial cells in both the small and large bowel (figure
1Aand 1B), which suggested a new hypothesis: apoptosis
of gut epithelium is the mechanism underlying the regenerative enteropathy of early infection.
To test this hypothesis, we quantified apoptosis of gut
epithelium over the course of early infection, with the
same tissues and time frame that we had used to document apoptosis of lamina propria CD4+ T cells (table 1 and
[12, 13]). As predicted by the hypothesis, we found large
increases in activated caspase 3+ gut epithelium lining the
small and large bowel. Increased apoptosis was detectable
in the exponential phase (7 dpi) of viral replication in the
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Figure 3. Increased proliferation of gut epithelial cells. Cycling cells were detected immunohistochemically by use of antibodies to
Ki67 and Vulcan Fast Red substrate. Sections were counterstained blue with Biocare hematoxylin. Before gut infection (day 0) (A),
most of the red-stained proliferating Ki67+ gut epithelial cells are either close to the base of the colonic crypts (encircled) or extend
only a short way toward the top (short arrow). At peak replication and gut epithelial cell apoptosis (B), increased numbers of Ki67+
gut epithelial cells extend from the base to nearly the tops of the crypts (long arrow). Original magnification, ×200. C, Percentage
of colonic Ki67+ gut epithelial cells, determined as described in Materials and Methods, in animals at the time points shown, corresponding to animals described in figure 2. Increased proliferation was detectable at 7 days postinoculation (dpi), peaked at 14 dpi,
and remained elevated at 28 dpi, the last time point of examination. Arrows point to the corresponding images in panels A and B.

gut, peaked at day 14 dpi, in parallel with peak viral replication, and then decreased by 28 dpi, the last time point examined in these studies [12]. We confirmed the activated
caspase-3 results by using antibodies to cleaved cytokeratin 18, a specific marker for epithelial cell apoptosis [14],
in colon-tissue sections stained with this antibody. Figure
2A–2C shows the increases in apoptosis of gut epithelium
at 7 and 14 dpi, compared with apoptosis in an uninfected
animal. We quantified the changes by using this marker in
apoptotic epithelial cells in the colons (figure 2D) of 2 animals before detection of SIV-infected cells in the gut (i.e., at
0–2 dpi) and in 8 animals after gut infection (2 animals each
in the exponential, peak, and decline phases [2 animals at
days 20/21 and 2 animals at day 28] of viral replication in
the gut tissues) [13]. The percentage of apoptotic epithelial
cells lining the colon at 7–8 dpi was 15-fold higher than either that in an uninfected animal or that in an infected animal before gut infection, was 30-fold higher at the peak
(i.e., at 14 dpi), and was still 8-fold higher at 28 dpi. There
was remarkably little interanimal variation (note that the
SEs for animals examined 1 or 2 days apart were small),

which attested to the reproducibility of the process, and all
the increases were highly statistically significant: P = 5.6 ×
10–6 overall and P = .004 when the percentage before infection of gut was compared with that at 28 dpi.
Gut epithelial cell proliferation and gut pathology in
early SIV infection. These increases suggested that, to
maintain mucosal integrity, gut epithelial cell apoptosis
might drive a compensatory increase in proliferation, as
an exaggeration of a normal homeostatic mechanism in the
gut, in which the integrity of the mucosal barrier is maintained by balancing the loss of apoptotic epithelial cells at
the tops of the crypts by replacement through division of
stem cells at the bases of the crypts [15]. We indeed documented increases in proliferation of gut epithelium that
are consistent with a compensatory response to increased
apoptosis. Using Ki67 as a marker for cell proliferation, we
detected increased numbers of Ki67+ gut epithelial cells,
and they continued to increase in parallel with gut epithelial apoptosis, peaking at highly significant (P > .001) levels, >3-fold higher than either those in an uninfected animal or those in an infected animal before gut infection. In
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regenerative villous atrophy in the small bowel that have
been described elsewhere [5, 7, 11]. Villous atrophy was already detectable at the second week of infection but was
most prominent at 28 dpi (figure 4A– 4C); at that time,
there was additional evidence of pathology in 1 animal in
which we found multiple microabscesses with neutrophilic
infiltrates (figure 4C).

Figure 4. Gut pathology. Sections of jejunum stained with hematoxylin and eosin, from animals before (A) and 28 dpi (B) infection, showing the shortened villi. C, 2 microabscesses with
neutrophilic infiltrates (arrows) in large bowel at 28 dpi. Original magnifications, ×100.

Gut epithelial cell apoptosis: possible mechanisms. We
investigated 4 mechanisms by which SIV infection and associated immune activation might induce gut epithelial
cell apoptosis. First, we found that productive infection of
gut epithelial cells is not likely to be the mechanism, because the only cells in which we detected SIVRNAby in
situ hybridization were mononuclear cells (MNCs) in the
lamina propria and lymphoid follicles (figure 5A), cells
that we had elsewhere shown to be memory CD4+ T cells
[13]. Second, because increased expression of Fas in enterocytes and Fas-L by intraepithelial or lamina propria
lymphocytes can induce gut epithelial cell apoptosis [16,
17], we assessed Fas and Fas-L expression and found that,
at the onset of increased gut epithelial cell apoptosis, there
was a correlation between focal increases in expression of
Fas in enterocytes and lamina propria lymphocytes (figure
5B) and Fas-L expression in lamina propria lymphocytes
(figure 5C), a correlation that is consistent with this second
mechanism. However, such a mechanism could not account for the peak of gut epithelial cell apoptosis at 14 dpi,
because, by that time, Fas-L+ lamina propria lymphocytes
had been largely depleted and Fas+ gut epithelial cells
were no longer detectable (not shown). Third, because
proinflammatory cytokine tumor-necrosis factor (TNF)–α
and interferon (IFN)–γ induce gut epithelial cell apoptosis
in vitro [18, 19], we investigated their expression.Wefound
that, at the onset of increased gut epithelial cell apoptosis, there were also increased numbers of cells positive for
TNF-α (figure 5D) and IFN-γ (not shown), findings that
are consistent with both a contribution to the initial increases in gut epithelial cell apoptosis and the previously
documented increased expression of IFN-γ and TNF-α
mRNA in gut and other tissues from these animals [20].
However, again, at the peak of gut epithelial cell apoptosis, we did not detect TNF-α+ cells by immunohistochemical staining (figure 5E), a result that is consistent with the
results of analyses of cytokinemRNAlevels in these animals, in which peak gut epithelial cell apoptosis occurs
at a time when TNF-α and IFN-γ mRNAs have been reported to be at their lowest level in the gut [20]. Thus, established mechanisms of gut epithelial apoptosis may play
a role in the initial increases in gut epithelial cell apoptosis
but cannot account for its peak level.

addition, the Ki67+ gut epithelial cells were not confined to
the bases but extended to the tops of the colonic crypts (figure 3A–3C).
The increased proliferation was associated with
the histopathological changes in acute SIV infection of

Gut epithelial cell apoptosis coincides with viral deposition at the basal surfaces of gut epithelial cells, and
transcytosis and shedding of GPR15/Bob. Peak gut epithelial cell apoptosis coincided with visible interactions between virus and GPR15/ Bob, an alternative coreceptor for
SIV [21] and HIV [22] and a mediator of CD4-independent
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Figure 5. Virus replication and expression of Fas, Fas-L, and tumor-necrosis factor (TNF)–α in gut. Simian immunodeficiency virus (SIV) RNA+ cells were detected by in situ hybridization using 35S-labeled SIV-specific riboprobes, as described in Materials
and Methods. In the developed radioautographs, the silver-grain signal from viral RNA imparts a white-yellow appearance to infected cells in reflected epipolarized light. A, SIV RNA+ lamina propria cells and SIV RNA– gut epithelial cells. The double-headed
arrow indicates 2 clusters of infected cells that are clearly in the lamina propria—i.e., gut epithelial cells are not productively infected. B and C, Immunohistochemical staining for Fas (B) and Fas-L (C), using substrates that impart a brown color to Fas+ cells
and a red color to Fas-L+ cells. The double-headed arrow in panel B indicates a cluster of Fas+ cells in lamina propria and overlying Fas+ gut epithelial cells in the large bowel at the onset of gut epithelial cell apoptosis, and panel C shows that, at that time,
there are increased numbers of Fas-L+ cells in lamina propria (encircled). D and E, Immunohistochemical staining for TNF-α. D,
Encircled cluster of brown TNF-α+ cells in lamina propria at the onset of gut infection. As shown in panel E, at peak apoptosis, 14
dpi, there are no detectable TNF- α+ cells. Original magnifications, ×400.

entry [23] that has been found to be implicated in HIV enteropathy [24, 25]. Before and at the onset of gut infection
in the animals, we detected only background levels of viral RNA in a particulate pattern characteristic of virions deposited along the basal surfaces of gut epithelium (figure
6A), and GPR15/Bob was mainly detectable at the basal
surfaces of gut epithelium, to a lesser extent at apical surfaces, and in MNCs in lamina propria of the small and
large bowel (figure 6B and 6C), just as has been described
as occurring in human gut tissues [24]. However, at the
peak of gut epithelial cell apoptosis, we observed a striking
pattern of virion binding to the basal surfaces of gut epithelium in the large bowel (figure 6D and 6E) and small bowel
(figure 6F), which coincided with a previously undescribed
and remarkable transcytosis and shedding of GPR15/ Bob
into the intestinal lumen (figure 6G and 6H). By 28 dpi,
there were concordant decreases in gut epithelial cell apoptosis, luminal shedding of GPR15/Bob, and increased expression of the latter at the basal and apical surfaces of gut
epithelium (figure 6I).

Discussion
The principal finding that we have reported here—that is,
massive gut epithelial cell apoptosis—now provides both
a mechanism for the regenerative enteropathy of early SIV
infection and an explanation for the increased expression
of cell-cycle genes that elsewhere have been documented in
microarray studies of SIV enteropathy [9, 10]. Although the
impact that this gut epithelial cell apoptosis– driven regenerative pathology has on the function of the gut mucosal
barrier cannot be directly determined by studies of fixed
tissues, barrier dysfunction has been documented in acute
SIV infection [6], and we also observed additional evidence
of histopathological changes in the gut, in the neutrophilic
microabscesses at 28 dpi. As has been recently proposed,
impaired function of the mucosal barrier could potentially
contribute to systemic immune activation, through microbial translocation [26, 27], which would help the virus to
maintain a persistent infection in the gut in 2 ways: (1) by
providing activated CD4+ T cell targets to sustain infection
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Figure 6. Virion deposition and translocation and shedding of GPR15/Bob. A and D–F, Virus association with GPR15/Bob. Viral
RNA in virions was detected by in situ hybridization using 35S-labeled simian immunodeficiency virus–specific riboprobes. In the
developed radioautographs, the silver grains that are the signal from virion RNA have a white-yellow to bluish appearance in reflected epipolarized light. A, Background levels of binding in the large bowel of an uninfected animal. D–E, Peak apoptosis. The
black arrow indicates silver grains in a particulate and diffuse pattern suggesting virion deposition along the basal surfaces of colonic crypts either oriented mainly longitudinally (D) or in cross-section (E). Original magnifications, ×200. F, Jejunal villi. The inset
(original magnification, ×400) shows a similar pattern of virions deposited at the basal surfaces of 1 of the jejunal villi in the section. Original magnification, ×100. B, C, and G–I, Changes in pattern of localization of GPR15/Bob in small and large bowel, associated with infection and gut epithelial cell apoptosis. GPR15/Bob was stained red, and gut epithelial cells were stained green,
with fluorophores and, respectively, antibodies to GPR15/Bob and to cytokeratins 5, 6, 8, 17, and 19. Nuclei were counterstained
blue with TOTO-3, as described in Materials and Methods. Original magnifications, ×600. B, GPR15/Bob before viral replication in
gut, localizing mainly to basal sides of gut epithelium (encircled) and to mononuclear cells in the lamina propria (small arrow). C,
Onset of viral replication. GPR15/Bob is still concentrated at the basal side of gut epithelium. G–H, Transcytosis and shedding of
GPR15/Bob at peak gut epithelial cell apoptosis. G, Vesicles of GPR15/Bob transiting the cell into the lumen. The arrow indicates
connections between GPR15/Bob in the lumen and an epithelial cell. The staining for cytokeratins reveals intact gut epithelial cells
below GPR15/Bob in the lumen, showing that luminal GPR15/Bob is not in shed apoptotic cells. H, Sections stained with antibodies and with fluorophores to GPR15/Bob (green) and cleaved cytokeratin 18 (red), as a marker for gut epithelial cell apoptosis. Colocalizing stains reveal transcytosing GPR15/Bob at the basal (b), middle (m), and top (t) in apoptotic gut epithelial cells. Note that
GPR15/Bob in the lumen (L) (green arrow) is not also stained with anticleaved cytokeratin 18 and thus is not shed into the lumen
in apoptotic gut epithelial cells. I, After peak of gut epithelial cell apoptosis. GPR15/Bob is concentrated at the basal and apical
surfaces of gut epithelial cells, with little evidence of transcytosis and shedding.

and (2) by blunting the SIV-specific CD8+ T cell response in
the gut [28], perhaps because of a countering immunosuppressive T regulatory response, as has been shown for peripheral lymph nodes [29].
SIV infection may induce gut epithelial cell apoptosis
by established as well as novel mechanisms whose relative
contributions will reflect the rapidly changing dynamics of

infection. At the onset of gut infection, there are rapid increases in lamina propria CD4 T cell apoptosis, which are
associated with parallel increases in Fas and Fas-L expression in lamina propria T cells, which we elsewhere have
proposed as being the mechanism of CD4 T cell apoptosis and the major mechanism of CD4 T cell depletion in
early infection [13]. Here we have shown that there are
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focal increases in Fas expression in intestinal epithelial cells
(IECs) overlying foci of Fas-L+ lamina propria mononuclear
cells, such that gut epithelial cell apoptosis may be induced
by these cells, which elsewhere has been proposed as the
mechanism of enterocyte apoptosis in celiac disease [17].
Proinflammatory cytokines IFN-γ and TNF-α might also
play a role in gut epithelial cell apoptosis, as they do in inflammatory bowel diseases [18, 19]. In their analysis of cytokinemRNAlevels in tissues from these animals, Abel et.
al. [20] have shown that there are increased levels of these
cytokines in the gut as well as in other tissues, and we have
shown here that there are increased numbers of TNF-α+
cells in the lamina propria at a time when IEC apoptosis
is increasing. However, TNF-α and IFN-γ mRNA levels in
the jejunum were actually lower than either those in uninfected control animals or those in infected animals before
gut infection [20], so these cytokines cannot account for gut
epithelial cell apoptosis in both small and large bowel.
Fas and Fas-L and cytokines also cannot be the principal
mechanism underlying peak gut epithelial cell apoptosis. We
have shown that there are few Fas-L+ cells in the lamina propria at 14 dpi, a finding that reflects the massive depletion of
CD4 T cells by this time. There are also few TNF-α+ cells at
14 dpi, which is in good agreement with the cytokinemRNAdata showing decreased mRNA levels at 14 dpi [20].
On the basis of both the observed striking focal deposition of virus and the coincident changes, at the peak of
gut epithelial cell apoptosis, in the expression and location
in gut epithelial cellassociated GPR15/Bob-IECs, we speculate that peak apoptosis might be the result of virotoxic effects that virion gp120 has on gut epithelial cells. In a previous study, such a virotoxic mechanism has been proposed
to account for both the loss of microtubules and the increased paracellular permeability observed in vitro, which
were the virotoxic effects of exposing cultured colonic cells
to HIV-1 gp120 [24]. Because apoptosis was not observed
in that previous in vitro study, we propose that IEC apoptosis in vivo is the result of what we have reported here—
that is, the demonstrable effect that much higher local concentrations of virion-associated gp120 has on GPR15/Bob
expression in gut epithelial cells, an effect that could trigger massive signaling and consequent apoptosis and observed changes in GPR15/Bob. The predisposition of terminally differentiated IECs to undergo apoptosis as they
near the luminal surface [30] is a necessary second component of this speculative model, to explain the restriction of
apoptosis when virus is deposited at the basal surfaces of
gut epithelial cells along the villi and crypts (figure 6).
The discovery of gut epithelial cell apoptosis as the underlying mechanism of the regenerative pathology of early
infection was the result of very close examination of tissues collected [12] in the stunningly fast phase of a slow infection, in which the most dramatic events unfold over a
period of 7 days. Thus, the power of this highly relevant
nonhuman primate model of HIV-1 infection is to enable
studies of pathogenic mechanisms that, by extension, may
apply to HIV-1 infection in humans but than cannot be
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studied in humans because the time frame in which they
are most evident precedes the earliest time when HIV-1–
infected individuals present with the symptoms of acute
retroviral infection [13, 31–33]. The speed with which SIV
induces apoptosis of both CD4 T cell populations and the
intestinal epithelium, with consequent pathological damage to the gut mucosa, attests to the need for new approaches to early interventions to prevent or greatly moderate the deleterious consequences that infection has on
adaptive and innate host defenses.
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